These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 11222470

  • 21. Evaluation of beta-blockers on left ventricular dyssynchrony and reverse remodeling in idiopathic dilated cardiomyopathy: A randomized trial of carvedilol and metoprolol.
    Kaya MG, Sarli B, Akpek M, Kaya EG, Yarlioglues M, Topsakal R, Lam YY.
    Cardiol J; 2014; 21(4):434-41. PubMed ID: 24142686
    [Abstract] [Full Text] [Related]

  • 22. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution.
    Rusconi P, Gómez-Marín O, Rossique-González M, Redha E, Marín JR, Lon-Young M, Wolff GS.
    J Heart Lung Transplant; 2004 Jul; 23(7):832-8. PubMed ID: 15261177
    [Abstract] [Full Text] [Related]

  • 23. Carvedilol in heart failure.
    Kelly DT.
    Cardiology; 1993 Jul; 82 Suppl 3():45-9. PubMed ID: 8106165
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul 15; 92(2):212-8. PubMed ID: 7600653
    [Abstract] [Full Text] [Related]

  • 26. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.
    Gilbert EM, Anderson JL, Deitchman D, Yanowitz FG, O'Connell JB, Renlund DG, Bartholomew M, Mealey PC, Larrabee P, Bristow MR.
    Am J Med; 1990 Mar 15; 88(3):223-9. PubMed ID: 1968710
    [Abstract] [Full Text] [Related]

  • 27. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E, Matsumura Y, Kubo T, Okawa M, Yamasaki N, Kitaoka H, Furuno T, Takata J, Doi YL.
    Am J Cardiol; 2011 Apr 01; 107(7):1065-70. PubMed ID: 21296328
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol.
    Metra M, Giubbini R, Nodari S, Boldi E, Modena MG, Dei Cas L.
    Circulation; 2000 Aug 01; 102(5):546-51. PubMed ID: 10920067
    [Abstract] [Full Text] [Related]

  • 30. A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy.
    Botoni FA, Poole-Wilson PA, Ribeiro AL, Okonko DO, Oliveira BM, Pinto AS, Teixeira MM, Teixeira AL, Reis AM, Dantas JB, Ferreira CS, Tavares WC, Rocha MO.
    Am Heart J; 2007 Apr 01; 153(4):544.e1-8. PubMed ID: 17383291
    [Abstract] [Full Text] [Related]

  • 31. Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.
    Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Tange S, Suzuki T, Kurabayashi M.
    J Nucl Med; 2004 Nov 01; 45(11):1878-84. PubMed ID: 15534058
    [Abstract] [Full Text] [Related]

  • 32. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.
    Krum H, Sackner-Bernstein JD, Goldsmith RL, Kukin ML, Schwartz B, Penn J, Medina N, Yushak M, Horn E, Katz SD.
    Circulation; 1995 Sep 15; 92(6):1499-506. PubMed ID: 7664433
    [Abstract] [Full Text] [Related]

  • 33. Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy.
    Neglia D, De Maria R, Masi S, Gallopin M, Pisani P, Pardini S, Gavazzi A, L'abbate A, Parodi O.
    Heart; 2007 Jul 15; 93(7):808-13. PubMed ID: 17237134
    [Abstract] [Full Text] [Related]

  • 34. Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure.
    Cohen Solal A, Jondeau G, Beauvais F, Berdeaux A.
    Eur J Heart Fail; 2004 Jun 15; 6(4):463-6. PubMed ID: 15182772
    [Abstract] [Full Text] [Related]

  • 35. Treatment of dilated cardiomyopathy with carvedilol in children.
    Erdoğan I, Ozer S, Karagöz T, Celiker A, Ozkutlu S, Alehan D.
    Turk J Pediatr; 2009 Jun 15; 51(4):354-60. PubMed ID: 19950843
    [Abstract] [Full Text] [Related]

  • 36. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z, Rayan M, Saleh A, Abdel-Barr MG, Hussain M, Nammas W.
    Cardiol J; 2015 Jun 15; 22(2):227-32. PubMed ID: 25179314
    [Abstract] [Full Text] [Related]

  • 37. The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy.
    Sliwa K, Skudicky D, Candy G, Bergemann A, Hopley M, Sareli P.
    Eur J Heart Fail; 2002 Jun 15; 4(3):305-9. PubMed ID: 12034156
    [Abstract] [Full Text] [Related]

  • 38. Digoxin-carvedilol interactions in children.
    Ratnapalan S, Griffiths K, Costei AM, Benson L, Koren G.
    J Pediatr; 2003 May 15; 142(5):572-4. PubMed ID: 12756393
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
    Agostini D, Belin A, Amar MH, Darlas Y, Hamon M, Grollier G, Potier JC, Bouvard G.
    J Nucl Med; 2000 May 15; 41(5):845-51. PubMed ID: 10809201
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.